Vanguard Personalized Indexing Management LLC Trims Stock Position in Kenvue Inc. $KVUE

Vanguard Personalized Indexing Management LLC lessened its stake in Kenvue Inc. (NYSE:KVUE) by 17.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 189,960 shares of the company’s stock after selling 41,039 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Kenvue were worth $3,092,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently made changes to their positions in the company. Salomon & Ludwin LLC purchased a new stake in shares of Kenvue in the 3rd quarter valued at about $25,000. NBT Bank N A NY increased its position in Kenvue by 180.3% during the third quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock worth $25,000 after buying an additional 1,006 shares during the period. Trust Co. of Vermont lifted its stake in Kenvue by 266.8% in the second quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock valued at $33,000 after buying an additional 1,150 shares during the last quarter. New England Capital Financial Advisors LLC lifted its stake in Kenvue by 81.4% in the third quarter. New England Capital Financial Advisors LLC now owns 2,563 shares of the company’s stock valued at $42,000 after buying an additional 1,150 shares during the last quarter. Finally, Future Financial Wealth Managment LLC acquired a new stake in shares of Kenvue in the third quarter valued at approximately $49,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Key Kenvue News

Here are the key news stories impacting Kenvue this week:

• Positive Sentiment: Shareholders of both companies overwhelmingly approved Kimberly‑Clark’s acquisition of Kenvue; the deal is on track to close in the second half of 2026, which likely provides a take‑over premium and near‑term certainty for Kenvue investors. Kimberly‑Clark and Kenvue Shareholders Overwhelmingly Approve Kimberly‑Clark’s Acquisition of Kenvue
• Positive Sentiment: Kenvue’s board declared a quarterly cash dividend of $0.2075 per share (payable Feb 25; record date Feb 11), implying a ~4.8% yield — a supportive income signal that may attract yield‑seeking investors ahead of the deal close. Kenvue Declares Quarterly Cash Dividend
• Positive Sentiment: Coverage framing the combination as a “household products mega‑merger” highlights scale and cross‑category reach (diapers to Tylenol), reinforcing strategic rationale for the deal and potential long‑term market power. From diapers to Tylenol: The household products mega‑merger that will serve half the world’s population
• Neutral Sentiment: Analyst coverage remains mixed: recent aggregator pieces and consensus data show a “Hold” rating on Kenvue, which may limit upside momentum despite the acquisition news. Kenvue stock: Analyst estimates & ratings
• Neutral Sentiment: Market watchers note upcoming earnings activity — Kenvue is projected to report soon — which could introduce short‑term volatility as investors reconcile reported results and FY‑2025 guidance with deal implications. Kenvue (KVUE) Projected to Post Earnings on Thursday
• Neutral Sentiment: Consensus analyst coverage summary also reiterates a “Hold” view, reflecting mixed expectations for standalone performance versus deal value capture. Kenvue Inc. (NYSE:KVUE) Given Consensus Rating of “Hold” by Analysts

Kenvue Trading Down 0.9%

Shares of Kenvue stock opened at $17.19 on Friday. The firm has a market cap of $32.93 billion, a price-to-earnings ratio of 22.91 and a beta of 0.60. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $25.17. The company’s 50-day simple moving average is $17.15 and its 200-day simple moving average is $18.07. The company has a quick ratio of 0.69, a current ratio of 0.98 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.The company had revenue of $3.76 billion for the quarter, compared to analyst estimates of $3.83 billion. During the same quarter in the previous year, the company earned $0.28 EPS. The firm’s revenue for the quarter was down 3.5% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, equities research analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th will be issued a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a yield of 4.8%. The ex-dividend date of this dividend is Wednesday, February 11th. Kenvue’s dividend payout ratio is currently 110.67%.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on KVUE shares. JPMorgan Chase & Co. cut their target price on shares of Kenvue from $24.00 to $21.00 and set an “overweight” rating on the stock in a report on Friday, October 10th. Evercore ISI set a $18.00 price objective on shares of Kenvue in a research note on Tuesday, October 28th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Kenvue in a report on Friday, January 9th. The Goldman Sachs Group decreased their target price on shares of Kenvue from $22.00 to $19.00 and set a “neutral” rating for the company in a research note on Thursday, October 2nd. Finally, Jefferies Financial Group cut Kenvue from a “buy” rating to a “hold” rating and set a $18.00 price target on the stock. in a research report on Friday. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and thirteen have issued a Hold rating to the company. Based on data from MarketBeat.com, Kenvue presently has a consensus rating of “Hold” and an average price target of $19.90.

Insiders Place Their Bets

In other Kenvue news, Director Jeffrey C. Smith acquired 3,200,000 shares of the business’s stock in a transaction on Friday, December 12th. The stock was purchased at an average price of $17.37 per share, for a total transaction of $55,584,000.00. Following the completion of the transaction, the director owned 27,307,632 shares of the company’s stock, valued at $474,333,567.84. The trade was a 13.27% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.68% of the stock is owned by corporate insiders.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.